SCHEMBL1594839

SCHEMBL1594839

CNC(=O)[C@@H](N)Cc1c[nH]c2c(Br)cccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS2 Q07890 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
MPO P05164 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
KMT2A Q03164 1/20 0.44
HIF1A Q16665 1/20 0.44
TNF P01375 1/20 0.42
MMP1 P03956 2/20 0.40
MMP3 P08254 2/20 0.40
MMP9 P14780 2/20 0.40
MMP8 P22894 2/20 0.40
TACR1 P25103 2/20 0.40
RUVBL1 Q9Y265 2/20 0.40
SOS1 Q07889 2/20 0.40
KRAS P01116 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19846987 0.86 SOS2 (0.48) SOS2KDM4EMEN1LMNAMPO
SCHEMBL27744607 0.85 SOS2 (0.45) SOS2KDM4EMEN1LMNAMPO
SCHEMBL1595190 0.85 SOS2 (0.45) SOS2KDM4EMEN1LMNAMPO
SCHEMBL18029211 0.84 MAPT (0.62) SOS2KDM4EMEN1LMNAMPO
SCHEMBL1594834 0.84 MAPT (0.62) SOS2KDM4EMEN1LMNAMPO
SCHEMBL1594831 0.84 MAPT (0.62) SOS2KDM4EMEN1LMNAMPO
Hydrochloric Acid SCHEMBL3999371 0.84 TACR1 (0.44) SOS2KDM4EMEN1LMNAMPO
SCHEMBL1596046 0.81 SCN9A (0.50) SOS2KDM4EMEN1LMNAMPO
SCHEMBL876693 0.79 KDM4E (0.70) KDM4EMEN1LMNAMPOMAPT
SCHEMBL29850214 0.79 KDM4E (0.70) KDM4EMEN1LMNAMPOMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1865950-B1 COMPOUNDS USEFUL AS MODULATORS OF THE PROTEASOME ACTIVITY CENTRE NAT RECH SCIENT (FR) 2013-08-28 EP disclosed
US-7919468-B2 Compounds useful as modulators of the proteasome activity CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2011-04-05 US disclosed
US-7919468-B2 Compounds useful as modulators of the proteasome activity CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2011-04-05 US disclosed
US-20090069222-A1 Compounds Useful as Modulators of the Proteasome Activity CENTRE NATIONAL DE AL RECHERCHE SCIENTIFIQUE (FR) 2009-03-12 US disclosed
US-20090069222-A1 Compounds Useful as Modulators of the Proteasome Activity CENTRE NATIONAL DE AL RECHERCHE SCIENTIFIQUE (FR) 2009-03-12 US disclosed
EP-1865950-A1 COMPOUNDS USEFUL AS MODULATORS OF THE PROTEASOME ACTIVITY The Centre National de la Recherche Scientifique (FR) 2007-12-19 EP disclosed
WO-2006105811-A1 COMPOUNDS USEFUL AS MODULATORS OF THE PROTEASOME ACTIVITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2006-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069222-A1 Compounds Useful as Modulators of the Proteasome Activity PSMB10, PSMB11, PSMB6 SOS2 3352/4885KDM4E 2618/4885MEN1 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.